Quick Answer
KIORA PHARMACEUTICALS INC reported Research And Development Expense of $10.78 million for the year ending 2025.
- KIORA PHARMACEUTICALS INC showed an increase of +37.5% in Research And Development Expense from 2024 to 2025.
- This data is from KIORA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $92.4 thousand | Q3 2014: $111.6 thousand | Q1 2015: $321.4 thousand | Q2 2015: $604.1 thousand | Q3 2015: $407.6 thousand | Q1 2016: $914.0 thousand | Q2 2016: $2.48 million | Q3 2016: $2.45 million | Q1 2017: $1.82 million | Q2 2017: $2.26 million | Q3 2017: $3.18 million | Q1 2018: $2.52 million | Q2 2018: $1.84 million | Q3 2018: $2.26 million | Q1 2019: $721.5 thousand | Q2 2019: $763.9 thousand | Q3 2019: $2.41 million | Q1 2020: $938.0 thousand | Q2 2020: $631.1 thousand | Q3 2020: $985.9 thousand | Q1 2021: $1.28 million | Q2 2021: $1.44 million | Q3 2021: $1.63 million | Q1 2022: $707.9 thousand | Q2 2022: $567.2 thousand | Q3 2022: $1.33 million | Q1 2023: $438.3 thousand | Q2 2023: $1.39 million | Q3 2023: $1.09 million | Q1 2024: $1.68 million | Q2 2024: $2.05 million | Q3 2024: $2.18 million | Q1 2025: $2.53 million | Q2 2025: $2.59 million | Q3 2025: $2.73 million.
- Over the full 12 years of available data (2014 to 2025), KIORA PHARMACEUTICALS INC's Research And Development Expense has grown by 1,929.8%.
- Historical annual values: Fiscal year 2025: $10.78 million | Fiscal year 2024: $7.84 million | Fiscal year 2023: $4.03 million | Fiscal year 2022: $3.45 million | Fiscal year 2021: $5.35 million | Fiscal year 2020: $3.57 million | Fiscal year 2019: $5.39 million | Fiscal year 2018: $8.06 million | Fiscal year 2017: $10.33 million | Fiscal year 2016: $8.42 million | Fiscal year 2015: $2.72 million | Fiscal year 2014: $531.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: